Emily Mae Young starred in the iconic commercials as a child — and she recently reunited with the brand decades later ...

Bayer Aktiengesellschaft remains deeply undervalued despite ongoing operational and litigation headwinds, supporting a bullish stance. Q3/25 results were weak, but technicals and intrinsic value ...

The Trump administration has urged the U.S. Supreme Court to hear Bayer's case aimed at stopping thousands of cancer lawsuits over its Roundup weedkiller. Bayer CEO Bill Anderson joined "The Claman ...

Shares of Bayer BAYN0.88%increase; green up pointing triangle rose as much as 14% on Tuesday after the U.S. Solicitor General supported the company’s push for the Supreme Court to take up its Roundup ...

Bayer shares rose as much as 15% on Tuesday after the U.S. solicitor general backed the company’s bid to get the Supreme Court to curtail litigation alleging its Roundup pesticide causes cancer.

SAO PAULO, Nov 26 (Reuters) - German conglomerate Bayer (BAYGn.DE), opens new tab on Wednesday said it will sell a new soybean product called Intacta 5+ for farmers in Brazil, the world's largest ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals, a development that also helped a rival creating a competing drug. Bayer didn’t ...

Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has suffered setbacks over the past ...

BERLIN, Nov 23 (Reuters) - German pharma company Bayer (BAYGn.DE), opens new tab reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the ...

Bayer has built a home for Chinese biopharma companies. Located in Beijing, the Bayer E-Town Open Innovation Center will incubate local biotechs starting with Puhe BioPharma and Youngen Technology.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Durham biotech with big-name ...